‌

US Patent 11497751 Modulators of Rho-associated protein kinase

Patent 11497751 was granted and assigned to Redx Pharma PLC on November, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Redx Pharma PLC

0

Current Assignee

Redx Pharma PLC

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Thomas Pesnot0

Peter Bunyard0

Nicolas E. S. Guisot0

Liam Byrne0

Gary Pitt0

Clifford D. Jones0

Date of Patent

November 15, 2022

0

Patent Application Number

169649040

Date Filed

January 25, 2019

0

Patent Citations Received

US Patent 11878020 Modulators of Rho-associated protein kinase

0

Patent Primary Examiner

Daniel R Carcanague

0

CPC Code

0

0

0

0

0

0

0

This invention relates to novel compounds and pharmaceutical compositions comprising the same. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11497751 Modulators of Rho-associated protein kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.